Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancer (Q78709824)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

title

Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Angelo Sidoni

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

Vanesa Gregorc

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Vienna Ludovini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Lorenza Pistola

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Samir Darwish

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Irene Floriani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Antonio Cavaliere

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Massimo Scheibel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Verena De Angelis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Emilio Bucciarelli

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Maurizio Tonato

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

41-48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer

16 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Biological prognostic factors for early stage completely resected non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Types and localisation of p53 gene mutations: a report on 332 non-small cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Immunohistochemically detected p53 and P-glycoprotein predict the response to chemotherapy in lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

The TP53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Expression of p53 and glutathione S-transferase-pi relates to clinical drug resistance in non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

p53 mutations do not predict response to paclitaxel in metastatic nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Biological parameters on computed tomography guided fine needle aspiration biopsy from peripheral primary non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Tumor physiology and drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Multifactorial analysis of p53 alteration in human cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Analysis of p53 mutants for transcriptional activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Does immunointensity account for the differences in prognostic significance of Bcl-2 expression in non-small cell lung cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

bcl-2 protein in non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

p21Waf1/Cip1 acts in synergy with bcl-2 to confer multidrug resistance in a camptothecin-selected human lung-cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900391-4

7 January 2021

10.1016/S0169-5002(02)00391-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499093%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference